Intellia Therapeutics (NTLA) Earnings
|
Expand Research on NTLA
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.92 | N/A | N/A | $13.51M | N/A | N/A | N/A | ||
| 2/26/26 | Q425 | -$0.83 | -$0.96 | +$0.13 | N/A | $12.08M | N/A |  | | Details | |
| 2/19/26 |
Q425 | N/A | -$0.96 | N/A | N/A | $12.08M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.92 | -$1.01 | +$0.09 | $13.78M | $14.06M | N/A | | | Details | |
| 8/7/25 | Q225 | -$0.98 | -$1.03 | +$0.05 | $14.24M | $11.99M | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$1.03 | N/A | N/A | $11.99M | N/A | N/A | N/A | ||
| 5/8/25 | Q125 | -$1.10 | -$1.27 | +$0.17 | $16.63M | $12.79M | N/A | | | Details | |
| 2/20/25 |
Q424 | N/A | -$1.34 | N/A | N/A | $9.28M | N/A | N/A | N/A |
